共 29 条
[1]
Andringa G., Drukarch B., Bol J.G.J.M., de Bruin K., Sorman K., Habraken J.B.A., Et al., Pinhole SPECT imaging of dopamine transporters correlates with dopamine transporter immunohistochemical analysis in the MPTP mouse model of Parkinson’s disease, NeuroImage, 26, pp. 1150-1158, (2005)
[2]
Bega D., Gonzalez-Latapi P., Zadikoff C., Spies W., Simuni T., Is there a role for DAT-SPECT imaging in a specialty movement disorders practice?, Neurodegener Dis, 15, pp. 81-86, (2015)
[3]
Benamer T.S., Patterson J., Grosset D.G., Booij J., de Bruin K., van Royen E., Et al., Accurate differentiation of parkinsonism and essential tremor using visual assessment of [<sup>123</sup>I]-FP-CIT SPECT imaging: the [<sup>123</sup>I]-FP-CIT study group, Mov Disord, 15, pp. 503-510, (2000)
[4]
Bostrom F., Jonsson L., Minthon L., Londos E., Patients with Lewy body dementia use more resources than those with Alzheimer’s disease, Int J Geriatr Psychiatry, 22, pp. 713-719, (2007)
[5]
Bostrom F., Jonsson L., Minthon L., Londos E., Patients with dementia with Lewy bodies have more impaired quality of life than patients with Alzheimer disease, Alzheimer Dis Assoc Disord, 21, pp. 150-154, (2007)
[6]
Cummings J.L., Henchcliffe C., Schaier S., Simuni T., Waxman A., Kemp P., The role of dopaminergic imaging in patients with symptoms of dopaminergic system neurodegeneration, Brain, 134, pp. 3146-3166, (2011)
[7]
Darcourt J., Booij J., Tatsch K., Varrone A., Vander Borght T., Kapucu O.L., Et al., EANM procedure guidelines for brain neurotransmission SPECT using (<sup>123</sup>)I-labelled dopamine transporter ligands, version 2, Eur J Nucl Med Mol Imaging, 37, pp. 443-450, (2010)
[8]
Djang D.S.W., Janssen M.J.R., Bohnen N., Booij J., Henderson T.A., Herholz K., Et al., SNM practice guideline for dopamine transporter imaging with <sup>123</sup>I-ioflupane SPECT 1.0, J Nucl Med, 53, pp. 154-163, (2012)
[9]
Fearnley J.M., Lees A.J., Ageing and Parkinson’s disease: Substantia nigra regional selectivity, Brain, 114, pp. 2283-2301, (1991)
[10]
Gerasimou G., Costa D.C., Papanastasiou E., Bostanjiopoulou S., Arnaoutoglou M., Moralidis E., Et al., SPECT study with I-123-Ioflupane (DaTSCAN) in patients with essential tremor. Is there any correlation with Parkinson’s disease?, Ann Nucl Med, 26, pp. 337-344, (2012)